Fethiye Şahin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fethiye Şahin has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Deniz Taşkıran
Faculty of Medicine, Clinic of Obstetrics and Gynecology, Giresun University, Giresun, Turkey
2 shared publications - Orhan Ay
Department of Obstetrics and Gynaecology, Faculty of Medicine, Necmettin Erbakan University
2 shared publications - Pelin Bahçeci
Department of Obstetrics and Gynaecology, Faculty of Medicine, Necmettin Erbakan University
2 shared publications Ali Acar
Division of Perinatology, Department of Obstetrics and Gynecology Necmettin Erbakan University Faculty of Medicine, Konya, Turkey
1 shared publication- Ali Acar
Department of Obstetrics and Gynecology, Meram Faculty of Medicine, Necmettin Erbakan University, 42080 Konya, Türkiye
1 shared publication - Husnu Celik
Department of Obstetrics and Gynecology, Faculty of Medicine, Başkent University, Adana, Türkiye
1 shared publication
Latest Publications
- Open Access
- 31 July 2026
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 6 (3) , 209-217
Reproductive and obstetric outcomes after complete and partial hydatidiform mole: A single-center retrospective cohort study
Aim: To evaluate the reproductive and obstetric outcomes after complete hydatidiform mole (CHM) and partial hydatidiform mole (PHM) in a tertiary referral center. Materials and Methods: This retrospective cohort included 90 women with histologically confirmed molar pregnancy (65 CHM and 25 PHM) who were managed between 2015 and 2024. Cases with ectopic localization, uncertain diagnosis, missing essential data, or insufficient follow-up were excluded. Women with uterine preservation, no permanent contraception, reproductive age, and adequate follow-up were defined as the subgroup with potential for subsequent pregnancy and were included in the reproductive outcome analysis. Postmolar gestational trophoblastic neoplasia (GTN), occurrence of at least one subsequent pregnancy, outcomes of the first postmolar pregnancy, and obstetric outcomes of the first live birth were compared between CHM and PHM. Results: Among women with potential for subsequent pregnancy (43 CHM and 14 PHM), at least one subsequent pregnancy occurred in 22 (51.2%) and 8 (57.1%) women, respectively (p=0.697). When only the first subsequent pregnancy was considered, live birth, miscarriage, and recurrent molar pregnancy rates did not differ significantly between CHM and PHM groups (live birth: 63.6% vs 87.5%, p=0.374; miscarriage: 18.2% vs 12.5%, p=1.000; recurrent mole: 18.2% vs 0%, p=0.550). Obstetric outcomes of the first subsequent live birth were also comparable between groups, including gestational age at delivery (p=0.336), birthweight (p=0.924), Apgar scores (all p>0.05), and mode of delivery (p=1.000); all deliveries occurred at term. Fetal growth restriction, preeclampsia, uterine atony, and oligohydramnios did not differ significantly between groups (all p>0.05). No cases of preterm premature rupture of membranes (PPROM), premature rupture of membranes (PROM), placenta previa, placenta accreta spectrum, or placental abruption were observed. Conclusion: In this single-center cohort, fertility potential and obstetric outcomes appeared generally favorable after both CHM and PHM. However, subgroup comparisons should be interpreted cautiously, as the limited sample size, particularly in the PHM group, may have reduced the statistical power to detect meaningful between-group differences.
- 31 July 2026
- Published by Izzet Baysal Training and Research Hospital in Northwestern Medical Journal
- Vol. 6 (3) , 209-217
Open AccessReproductive and obstetric outcomes after complete and partial hydatidiform mole: A single-center retrospective cohort study
Aim: To evaluate the reproductive and obstetric outcomes after complete hydatidiform mole (CHM) and partial hydatidiform mole (PHM) in a tertiary referral center. Materials and Methods: This retrospective cohort included 90 women with histologically confirmed molar pregnancy (65 CHM and 25 PHM) who were managed between 2015 and 2024. Cases with ectopic localization, uncertain diagnosis, missing essential data, or insufficient follow-up were excluded. Women with uterine preservation, no permanent contraception, reproductive age, and adequate follow-up were defined as the subgroup with potential for subsequent pregnancy and were included in the reproductive outcome analysis. Postmolar gestational trophoblastic neoplasia (GTN), occurrence of at least one subsequent pregnancy, outcomes of the first postmolar pregnancy, and obstetric outcomes of the first live birth were compared between CHM and PHM. Results: Among women with potential for subsequent pregnancy (43 CHM and 14 PHM), at least one subsequent pregnancy occurred in 22 (51.2%) and 8 (57.1%) women, respectively (p=0.697). When only the first subsequent pregnancy was considered, live birth, miscarriage, and recurrent molar pregnancy rates did not differ significantly between CHM and PHM groups (live birth: 63.6% vs 87.5%, p=0.374; miscarriage: 18.2% vs 12.5%, p=1.000; recurrent mole: 18.2% vs 0%, p=0.550). Obstetric outcomes of the first subsequent live birth were also comparable between groups, including gestational age at delivery (p=0.336), birthweight (p=0.924), Apgar scores (all p>0.05), and mode of delivery (p=1.000); all deliveries occurred at term. Fetal growth restriction, preeclampsia, uterine atony, and oligohydramnios did not differ significantly between groups (all p>0.05). No cases of preterm premature rupture of membranes (PPROM), premature rupture of membranes (PROM), placenta previa, placenta accreta spectrum, or placental abruption were observed. Conclusion: In this single-center cohort, fertility potential and obstetric outcomes appeared generally favorable after both CHM and PHM. However, subgroup comparisons should be interpreted cautiously, as the limited sample size, particularly in the PHM group, may have reduced the statistical power to detect meaningful between-group differences.
- 3 July 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (3) , 1577-1588
Comparison of outpatient versus inpatient management after early stabilization in preterm prelabor rupture of membranes <34 weeks: Maternal safety, latency, and neonatal outcomes
Objective: This study compared outpatient/home follow‐up after initial stabilization with inpatient management in singleton pregnancies with preterm prelabor rupture of membranes (PPROM) before 34 + 0 weeks of gestation, focusing on maternal safety, neonatal outcomes, latency, and healthcare utilization. Materials and Methods: In this single‐center retrospective cohort, singleton PPROM cases managed between January 2020 and December 2024 were evaluated. After stabilization, patients were classified as outpatient/home or inpatient. The primary outcome was neonatal intensive care unit (NICU) admission. Inverse probability of treatment weighting (IPTW) was used to reduce selection bias, and latency was assessed with landmark Kaplan–Meier analyses. Results: A total of 239 cases were analyzed (inpatient, n = 173; outpatient/home, n = 66). NICU admission was lower in the outpatient/home group (unadjusted risk ratio [RR] 0.56; IPTW RR 0.59, P = 0.007). The outpatient/home group had higher gestational age at delivery (median 36 vs. 31 weeks), shorter NICU stay (IPTW median difference, −4 days), and greater birth weight (IPTW median difference, +980 g). Placental abruption was more frequent in the outpatient/home group (IPTW RR 2.48). Landmark analyses showed markedly longer additional latency in the outpatient/home group (after 48 h: 43 vs. 3 days; after 7 days: 38 vs. 5 days; log‐rank P < 0.001). Conclusion: In carefully selected, initially stable PPROM cases before 34 weeks, outpatient/home management was associated with longer latency and lower NICU utilization. However, these findings should be interpreted cautiously because more stable patients might have been preferentially selected for outpatient follow‐up. With careful selection and close surveillance, outpatient/home management might be a reasonable alternative to reduce inpatient resource use.
- 3 July 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 175 (3) , 1577-1588
Comparison of outpatient versus inpatient management after early stabilization in preterm prelabor rupture of membranes <34 weeks: Maternal safety, latency, and neonatal outcomes
Objective: This study compared outpatient/home follow‐up after initial stabilization with inpatient management in singleton pregnancies with preterm prelabor rupture of membranes (PPROM) before 34 + 0 weeks of gestation, focusing on maternal safety, neonatal outcomes, latency, and healthcare utilization. Materials and Methods: In this single‐center retrospective cohort, singleton PPROM cases managed between January 2020 and December 2024 were evaluated. After stabilization, patients were classified as outpatient/home or inpatient. The primary outcome was neonatal intensive care unit (NICU) admission. Inverse probability of treatment weighting (IPTW) was used to reduce selection bias, and latency was assessed with landmark Kaplan–Meier analyses. Results: A total of 239 cases were analyzed (inpatient, n = 173; outpatient/home, n = 66). NICU admission was lower in the outpatient/home group (unadjusted risk ratio [RR] 0.56; IPTW RR 0.59, P = 0.007). The outpatient/home group had higher gestational age at delivery (median 36 vs. 31 weeks), shorter NICU stay (IPTW median difference, −4 days), and greater birth weight (IPTW median difference, +980 g). Placental abruption was more frequent in the outpatient/home group (IPTW RR 2.48). Landmark analyses showed markedly longer additional latency in the outpatient/home group (after 48 h: 43 vs. 3 days; after 7 days: 38 vs. 5 days; log‐rank P < 0.001). Conclusion: In carefully selected, initially stable PPROM cases before 34 weeks, outpatient/home management was associated with longer latency and lower NICU utilization. However, these findings should be interpreted cautiously because more stable patients might have been preferentially selected for outpatient follow‐up. With careful selection and close surveillance, outpatient/home management might be a reasonable alternative to reduce inpatient resource use.
- 1 June 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (6) , 599-604
Sacrospinous ligament fixation versus posterior intravaginal slingplasty for apical pelvic organ prolapse: a prospective randomized controlled trial
Aim To compare the short-term anatomical and functional outcomes of sacrospinous ligament fixation (SSLF) and posterior intravaginal slingplasty (PIVS) in women with apical pelvic organ prolapse (POP). Methods This single-center, prospective randomized controlled trial was conducted at Fırat University Faculty of Medicine between September 2007 and October 2008. Forty women with stage II or higher apical POP were randomized to undergo SSLF (n = 20) or PIVS (n = 20). The primary outcome was anatomical success at six weeks, defined as POP-Q stage < II. Secondary outcomes included operative time, blood loss, perioperative complications, postoperative pain (VAS), hospital stay, quality-of-life and sexual function scores (PFDI-20, PFIQ-7, PISQ-12, PQoL), and patient satisfaction. Statistical analysis was performed using Student’s t, Mann–Whitney U, and chi-square tests, with p<0.05 considered significant. Results Baseline characteristics were comparable between groups. PIVS was associated with a shorter mean hospital stay (2.6 vs. 3.7 days, p=0.004) and lower postoperative pain scores (2.9 vs. 4.3, p=0.001). At six weeks, anatomical success was achieved in 80% of SSLF and 85% of PIVS patients (p=0.71). Functional outcomes and patient satisfaction were comparable, and no early mesh erosion was observed. Conclusion Both SSLF and PIVS provided effective short-term correction of apical prolapse. Considering its mesh-free design and favorable safety profile, SSLF remains the preferred native-tissue vaginal approach. Longer-term studies are warranted to confirm durability and comparative outcomes.
- 1 June 2026
- Published by Bayrakol Medical Publishing in Journal of Clinical and Analytical Medicine
- Vol. 17 (6) , 599-604
Sacrospinous ligament fixation versus posterior intravaginal slingplasty for apical pelvic organ prolapse: a prospective randomized controlled trial
Aim To compare the short-term anatomical and functional outcomes of sacrospinous ligament fixation (SSLF) and posterior intravaginal slingplasty (PIVS) in women with apical pelvic organ prolapse (POP). Methods This single-center, prospective randomized controlled trial was conducted at Fırat University Faculty of Medicine between September 2007 and October 2008. Forty women with stage II or higher apical POP were randomized to undergo SSLF (n = 20) or PIVS (n = 20). The primary outcome was anatomical success at six weeks, defined as POP-Q stage < II. Secondary outcomes included operative time, blood loss, perioperative complications, postoperative pain (VAS), hospital stay, quality-of-life and sexual function scores (PFDI-20, PFIQ-7, PISQ-12, PQoL), and patient satisfaction. Statistical analysis was performed using Student’s t, Mann–Whitney U, and chi-square tests, with p<0.05 considered significant. Results Baseline characteristics were comparable between groups. PIVS was associated with a shorter mean hospital stay (2.6 vs. 3.7 days, p=0.004) and lower postoperative pain scores (2.9 vs. 4.3, p=0.001). At six weeks, anatomical success was achieved in 80% of SSLF and 85% of PIVS patients (p=0.71). Functional outcomes and patient satisfaction were comparable, and no early mesh erosion was observed. Conclusion Both SSLF and PIVS provided effective short-term correction of apical prolapse. Considering its mesh-free design and favorable safety profile, SSLF remains the preferred native-tissue vaginal approach. Longer-term studies are warranted to confirm durability and comparative outcomes.
- 4 December 2025
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 234 (5) , e213
Toward biomarker-informed multimodal risk stratification
- 4 December 2025
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 234 (5) , e213
Toward biomarker-informed multimodal risk stratification